Trials / Completed
CompletedNCT05952960
Optimizing Open Label Placebo Rationales
Optimizing Open Label Placebo Rationales for Chronic Pain
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 11 (actual)
- Sponsor
- Rhode Island Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
A 3-arm randomized trial where all chronic pain patients will receive honest placebos, but the information about the placebos will differ between conditions. Outcomes are measured for 21 days and a qualitative survey will be conducted.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Placebo | Open Label Placebo + Rationale |
Timeline
- Start date
- 2023-07-15
- Primary completion
- 2023-12-31
- Completion
- 2023-12-31
- First posted
- 2023-07-19
- Last updated
- 2025-07-28
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05952960. Inclusion in this directory is not an endorsement.